InspireMD
NSPR | NASDAQ
$0.60
-$0.04 (-6.85%)
At close: Nov 16, 2026, 4:00 PM ET
$0.61
+$0.01 (+2.00%)
After-hours:
Nov 16, 2026, 5:49 PM ET
-6.85%
(1D)No price chart data available for 1D timeframe.
Rating
27.2
Fundamentals Weak
Market Sentiment Neutral
Moat None
Sector Rank #872/1021 (Top 85%)
Key Statistics
Market Data
Market Cap $51.37M
1D Range
0.59 0.65
52W Range
0.44 2.15
Valuation (TTM)
PE -1.33
PB 2.36
EV/EBITDA -0.97
Valuation (NTM)
Forward PE N/A
Forward PEG 0.05
Price Target $4.50
Cash Flow
FCF Yield -82.7%
SBC Adj. FCF Yield -103.5%
SBC Impact -25.2%
Margins
Gross Margin 12.6%
Operating Margin -477.8%
FCF Margin -402.1%
Growth (CAGR)
Revenue 3Y | 5Y 24.5% |
26.4%
Dil EPS 3Y | 5Y 27.5% |
36.5%
FCF 3Y | 5Y -38.7% |
-28.2%
Returns
ROA -105.9%
ROE -93.5%
ROIC -201.8%
Financial Health
Net Cash
$19.25M
Current Ratio 2.99
Interest Coverage 0.00
Dividends
Div Yield N/A
Payout Ratio N/A
FCF Payout Ratio N/A
Loading financial charts...
Profile
InspireMD, Inc., an Israel-based medical technology company established in 2005, specializes in creating and commercializing advanced medical devices. Its core expertise lies in the proprietary MicroN...
Sector Healthcare
Industry Medical - Devices
Employees 127
IPO Date Apr 12, 2011
Website www.inspiremd.com
Fiscal Year January - December
Latest News
No news articles available yet.
Earnings
Latest Earnings
Nov 12, 2026
EPS
-$0.11
Beat +28.26%
YoY:
+35.29% REV
$2.24M
Beat +12.32%
YoY:
-11.14%Next Earnings
Mar 17, 2027
EPS Est
Pro
Rev Est
Pro
Analyst Summary
# of Analysts
1
Consensus
Buy
Price Target
$4.50
Upside
+650.00%
Buy (1)
Hold (0)
Sell (0)
Add to Watchlist
Select watchlists to add or remove NSPR